dsp 4 has been researched along with oxidopamine in 67 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (53.73) | 18.7374 |
| 1990's | 14 (20.90) | 18.2507 |
| 2000's | 10 (14.93) | 29.6817 |
| 2010's | 7 (10.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniels, WM; Jaffer, A; Russell, VA; Taljaard, JJ | 1 |
| Riekkinen, M; Riekkinen, P; Sirviö, J; Valjakka, A | 1 |
| Chan, JY; Chan, SH; Pan, S | 1 |
| Fritschy, JM; Grzanna, R | 1 |
| Depaulis, A; Kempf, E; Lannes, B; Marescaux, C; Micheletti, G; Vergnes, M; Warter, JM | 1 |
| Nowak, G; Superata, J; Zak, J | 1 |
| Berger, B; Febvret, A; Gaspar, P; Verney, C | 1 |
| Cornwell-Jones, CA; Decker, MW; Gianulli, T; McGaugh, JL; Wright, EL | 1 |
| Curzon, G; Hutson, PH | 1 |
| Fujita, S; Fukuda, T; Izumi, K; Koja, T; Ohba, N; Shimizu, T; Sorimachi, M | 1 |
| Bardelay, C; Marcel, D; Meunier, C; Pujol, JF; Weissmann, D | 1 |
| Berger, B; Febvret, A; Helle, KB; Verney, C; Vigny, A | 1 |
| Chapin, DS; Lookingland, KJ; McKay, DW; Moore, KE | 1 |
| Pucilowski, O; Valzelli, L | 1 |
| Archer, T; Danysz, W; Minor, BG; Persson, ML; Post, C; Sundström, E | 1 |
| Archer, T; Arweström, E; Jonsson, G; Minor, BG; Persson, ML; Post, C; Sundström, E | 1 |
| Dunwiddie, TV; Yasuda, RP; Zahniser, NR | 1 |
| Archer, T; Jonsson, G; Minor, BG; Post, C | 1 |
| Archer, T; Fredriksson, A; Jonsson, G; Lewander, T; Mohammed, AK; Ross, SB; Söderberg, U | 1 |
| Archer, T; Danysz, W; Fowler, CJ; Magnusson, O; Mohammed, AK | 1 |
| de Jong, W; van den Buuse, M; Versteeq, DH | 1 |
| Archer, T; Jonsson, G; Minor, BG; Mohammed, AK; Post, C | 1 |
| Esposito, E; Mennini, T; Merlo-Pich, E; Romandini, S; Samanin, R | 1 |
| Archer, T; Callenholm, NE; Järbe, TU; Mohammed, AK | 1 |
| Esposito, E; Ossowska, G; Samanin, R | 1 |
| Goldstein, M; Jonsson, G; Luthman, J; Sundström, E | 1 |
| Fibiger, HC; Spyraki, C | 2 |
| Berger, B; Descarries, L; Doucet, G | 1 |
| Kostrzewa, RM | 2 |
| Davis, M; Kehne, JH | 1 |
| Chrobak, JJ; Dehaven, DL; Hanin, I; Tilson, HA; Walsh, TJ | 1 |
| Frondoza, CG; Grzanna, R; Otten, U | 1 |
| Daw, NW; Parkinson, D; Rader, RK; Videen, TO | 1 |
| Archer, T; Danysz, W; Jonsson, G; Mohammed, AK | 1 |
| Medina, JH; Novas, ML | 1 |
| De Robertis, E; Medina, JH; Novas, ML | 1 |
| Langer, SZ; Pimoule, C; Scatton, B | 1 |
| Hallman, H; Jonsson, G | 1 |
| Jaim-Etcheverry, G; Zieher, LM | 1 |
| Bickford, PC; Freedman, R; Hoffer, BJ; Mosimann, WF | 1 |
| Anisman, H; Beauchamp, C; Bruto, V; Zacharko, RM | 1 |
| Kubos, KL; Moran, TH; Robinson, RG; Saad, KM | 1 |
| Hallman, H; Jonsson, G; Ponzio, F | 1 |
| Matsumoto, K; Ojima, K; Tohda, M; Watanabe, H | 1 |
| Boya, J; López-Muñoz, F | 1 |
| Cirelli, C; Pompeiano, M; Tononi, G | 1 |
| Cheng, JT; Hsieh, CH; Hsieh, JT; Lai, MK; Liu, SP | 1 |
| Burunda, T; Dunn, AJ; Patterson, B; Swiergiel, AH | 1 |
| Tieu, K; Yu, PH; Zuo, DM | 1 |
| Fujiwara, M; Hatip-Al-Khatib, I; Iwasaki, K; Mishima, K | 1 |
| Cryan, JF; Lucki, I; Page, ME | 1 |
| Schmidt, WJ; Srinivasan, J | 2 |
| Blier, P; Haddjeri, N; Lavoie, N | 1 |
| Bechtholt, AJ; Crowley, JJ; Lucki, I; O'Leary, OF; Valentino, RJ | 1 |
| Barbanoj, M; Kulisevsky, J; Pérez, V; Rodríguez-Alvarez, J; Rubio, A; Sosti, V | 1 |
| Barbanoj, M; Gich, I; Kulisevsky, J; Pérez, V; Rodríguez-Alvarez, J; Rubio, A; Sosti, V | 1 |
| Aguilar, E; Barbanoj, M; Kulisevsky, J; Marin, C; Pérez, V; Rubio, A | 1 |
| Benazzouz, A; Delaville, C; Navailles, S | 1 |
| Giordano, G; Harkavyi, A; Lever, R; Rampersaud, N; Whitton, J; Whitton, P | 1 |
| Björklund, A; Carta, M; Devoto, P; Rogers, JT; Shin, E | 1 |
| Huang, C; Liu, J; Wang, HS; Wang, T; Wang, Y | 1 |
| Chen, X; Han, LN; Huang, C; Li, LB; Liu, J; Sun, YN; Wang, T; Wang, Y; Wu, ZH; Zhang, L | 1 |
| Benazzouz, A; Delaville, C; Faggiani, E | 1 |
| Cao, LF; Chen, LH; Cheng, RX; Huang, Y; Liu, T; Luo, WF; Peng, XY; Wang, B; Zhou, FM | 1 |
4 review(s) available for dsp 4 and oxidopamine
| Article | Year |
|---|---|
Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
Topics: Adrenergic Agents; Adrenergic Fibers; Axons; Benzylamines; Cerebral Cortex; Dopamine beta-Hydroxylase; Drug Resistance; Hypothalamus; Locus Coeruleus; Nerve Degeneration; Neurotransmitter Uptake Inhibitors; Norepinephrine; Oxidopamine; Synaptosomes | 1991 |
Reorganization of noradrenergic neuronal systems following neonatal chemical and surgical injury.
Topics: Adrenergic Fibers; Animals; Benzylamines; Brain; Dihydroxyphenylalanine; Guanethidine; Hydroxydopamines; Mice; Neurotoxins; Norepinephrine; Oxidopamine; Rats | 1988 |
Response of central monoamine neurons following an early neurotoxic lesion.
Topics: Animals; Benzylamines; Brain; Brain Chemistry; Central Nervous System; Hydroxydopamines; Methylazoxymethanol Acetate; Neurons; Neurotoxins; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1982 |
Evolution of neurotoxins: from research modalities to clinical realities.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Animals; Benzylamines; Botulinum Toxins, Type A; Dihydroxyphenylalanine; Dihydroxytryptamines; Glutamic Acid; Humans; Models, Animal; Nerve Growth Factor; Neurosciences; Neurotoxins; Oxidopamine; Terminology as Topic | 2009 |
63 other study(ies) available for dsp 4 and oxidopamine
| Article | Year |
|---|---|
Effects of alpha 2- and beta-adrenoceptor agonists on growth hormone secretion following lesion of the noradrenergic system of the rat.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Benzylamines; Clonidine; Dopamine; Frontal Lobe; Growth Hormone; Hippocampus; Hypothalamus; Isoproterenol; Male; Medial Forebrain Bundle; Norepinephrine; Oxidopamine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Serotonin | 1992 |
DSP-4, a noradrenergic neurotoxin, produces more severe biochemical and functional deficits in aged than young rats.
Topics: Aging; Animals; Benzylamines; Brain Chemistry; Choline O-Acetyltransferase; Dopamine; Electroencephalography; Male; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin; Sympathomimetics | 1992 |
Participation of noradrenergic neurotransmission in angiotensin III-induced dipsogenic behavior in the rat.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Benzylamines; Carbachol; Dose-Response Relationship, Drug; Drinking Behavior; Drug Interactions; Hydroxydopamines; Injections, Intravenous; Male; Norepinephrine; Oxidopamine; Phentolamine; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Sympathomimetics; Synaptic Transmission; Yohimbine | 1991 |
Lesions of noradrenergic neurons in rats with spontaneous generalized non-convulsive epilepsy.
Topics: Animals; Animals, Newborn; Benzylamines; Brain Chemistry; Corpus Callosum; Electric Stimulation; Electroencephalography; Epilepsy, Generalized; Injections; Locus Coeruleus; Mesencephalon; Neurons; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Sympathomimetics | 1991 |
Role of dopaminergic neurons in denervation-induced alpha 1-adrenergic up-regulation in the rat cerebral cortex.
Topics: Animals; Benzylamines; Cerebral Cortex; Dopamine; Hydroxydopamines; Male; Neurons; Neurotoxins; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Up-Regulation | 1991 |
Further indication that distinct dopaminergic subsets project to the rat cerebral cortex: lack of colocalization with neurotensin in the superficial dopaminergic fields of the anterior cingulate, motor, retrosplenial and visual cortices.
Topics: Animals; Benzylamines; Cerebral Cortex; Dopamine; Hippocampus; Hydroxydopamines; Immunohistochemistry; Motor Cortex; Neurons, Afferent; Neurotensin; Oxidopamine; Rats; Rats, Inbred Strains; Sympathomimetics; Visual Cortex | 1991 |
Norepinephrine depletion reduces the effects of social and olfactory experience.
Topics: Adaptation, Physiological; Animals; Benzylamines; Brain; Choice Behavior; Choline; Hydroxydopamines; Male; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Smell; Social Behavior; Stress, Physiological | 1990 |
Dopamine metabolites in rat cisternal cerebrospinal fluid: major contribution from extrastriatal dopamine neurones.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzylamines; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Dopamine; Hippocampus; Homovanillic Acid; Humans; Hydroxydopamines; Hydroxyindoleacetic Acid; Male; Neurons; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin | 1986 |
Capsaicin-induced corneal lesions in mice and the effects of chemical sympathectomy.
Topics: Animals; Animals, Newborn; Benzylamines; Capsaicin; Cornea; Hydroxydopamines; Male; Mice; Norepinephrine; Oxidopamine; Substance P; Sympathectomy, Chemical | 1987 |
Benzodiazepine binding sites in the cingulate cortex after lesion of the noradrenaline and dopamine containing afferents.
Topics: Afferent Pathways; Animals; Autoradiography; Benzylamines; Binding Sites; Dopamine; Flunitrazepam; Gyrus Cinguli; Hydroxydopamines; Male; Medial Forebrain Bundle; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, GABA-A; Serotonin | 1987 |
Postnatal ontogenesis of the dopaminergic innervation in the rat anterior cingulate cortex (area 24). Immunocytochemical and catecholamine fluorescence histochemical analysis.
Topics: Adrenergic Fibers; Animals; Benzylamines; Catecholamines; Dopamine; Gyrus Cinguli; Histocytochemistry; Hydroxydopamines; Oxidopamine; Rats; Rats, Inbred Strains; Synaptic Transmission; Tyrosine 3-Monooxygenase | 1985 |
Comparative effects of the neurotoxins N-chloroethyl-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) and 6-hydroxydopamine on hypothalamic noradrenergic, dopaminergic and 5-hydroxytryptaminergic neurons in the male rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amines; Animals; Benzylamines; Brain Chemistry; Dopamine; Hydroxydopamines; Hypothalamus; Male; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Rats; Serotonin | 1986 |
Chemical lesions of the nucleus accumbens septi in rats: effects on muricide and apomorphine-induced aggression.
Topics: 5,7-Dihydroxytryptamine; Aggression; Animals; Apomorphine; Benzylamines; Dopamine; Hydroxydopamines; Male; Neurotransmitter Agents; Norepinephrine; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains; Septal Nuclei; Serotonin; Synaptic Transmission | 1986 |
Increased antinociception by alpha-adrenoceptor drugs after spinal cord noradrenaline depletion.
Topics: Adrenergic alpha-Agonists; Analgesia; Animals; Benzylamines; Clonidine; Guanfacine; Guanidines; Hydroxydopamines; Injections, Spinal; Male; Morphine; Norepinephrine; Oxidopamine; Phenylacetates; Rats; Rats, Inbred Strains; Spinal Cord | 1987 |
(+)-8-OH-DPAT and 5-MeODMT induced analgesia is antagonised by noradrenaline depletion.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analgesia; Animals; Benzylamines; Hydroxydopamines; Male; Methoxydimethyltryptamines; Mice; Mice, Inbred Strains; Naphthalenes; Nociceptors; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin; Tetrahydronaphthalenes | 1987 |
The acute effects of 6-hydroxydopamine treatment on noradrenergic function in the rat hippocampus in vitro.
Topics: Adrenergic Fibers; Animals; Benzylamines; Cyclic AMP; Hippocampus; Hydroxydopamines; In Vitro Techniques; Male; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1986 |
Noradrenergic-serotonergic interactions and nociception in the rat.
Topics: 5,7-Dihydroxytryptamine; Animals; Benzylamines; Hydroxydopamines; Male; Methoxydimethyltryptamines; Nociceptors; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Reaction Time; Serotonin | 1986 |
Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.
Topics: Animals; Benzylamines; Central Nervous System; Desipramine; Dextroamphetamine; Drug Interactions; Hydroxydopamines; Male; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains | 1986 |
The effect of selective noradrenergic lesions upon the stimulation by noradrenaline of inositol phospholipid breakdown in rat hippocampal miniprisms.
Topics: Animals; Benzylamines; Hippocampus; Hydroxydopamines; In Vitro Techniques; Inositol; Inositol Phosphates; Locus Coeruleus; Male; Norepinephrine; Oxidopamine; Phospholipids; Rats; Rats, Inbred Strains; Sugar Phosphates; Sympathectomy, Chemical | 1986 |
Brain noradrenaline and the development of hypertension: the effect of treatment with central 6-hydroxydopamine or DSP-4.
Topics: Animals; Benzylamines; Brain Chemistry; Catecholamines; Hydroxydopamines; Hypertension; Male; Neurotoxins; Norepinephrine; Oxidopamine; Rats; Rats, Inbred SHR | 1986 |
5-HT agonist induced analgesia modulated by central but not peripheral noradrenaline depletion in rats.
Topics: 5,7-Dihydroxytryptamine; Animals; Benzylamines; Central Nervous System; Hydroxydopamines; Male; Methoxydimethyltryptamines; Norepinephrine; Oxidopamine; Pain; Peripheral Nerves; Rats; Rats, Inbred Strains; Serotonin | 1986 |
Evidence of the involvement of dopamine in the analgesic effect of nefopam.
Topics: 5,7-Dihydroxytryptamine; Analgesics; Animals; Benzylamines; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain Chemistry; Catecholamines; Desipramine; Dopamine; Hydroxydopamines; Injections, Intraventricular; Male; Nefopam; Oxazocines; Oxidopamine; Rats; Reserpine | 1986 |
Noradrenaline and the context-dependent extinction effect.
Topics: Animals; Avoidance Learning; Benzylamines; Brain; Brain Mapping; Cues; Extinction, Psychological; Hydroxydopamines; Male; Neural Pathways; Norepinephrine; Oxidopamine; Rats; Saccharin; Taste | 1986 |
Further evidence that noradrenaline is not involved in the anti-immobility activity of chronic desipramine in the rat.
Topics: Animals; Benzylamines; Brain Chemistry; Desipramine; Hydroxydopamines; Immobilization; Injections; Locus Coeruleus; Male; Motor Activity; Norepinephrine; Oxidopamine; Rats; Sympathectomy, Chemical | 1987 |
Determination of monoamines by use of liquid chromatography with electrochemical detection in the study of selective monoamine neurotoxins.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Animals, Newborn; Benzylamines; Brain; Chromatography, High Pressure Liquid; Dopamine; Hydroxydopamines; Neurotoxins; Norepinephrine; Oxidopamine; Pyridines; Rats; Serotonin | 1987 |
A role for the mesolimbic dopamine system in the reinforcing properties of diazepam.
Topics: Animals; Benzylamines; Choice Behavior; Conditioning, Operant; Diazepam; Dopamine; Hydroxydopamines; Limbic System; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reinforcement, Psychology; Sympathomimetics | 1988 |
Density of the dopamine innervation in rat cerebral cortex after neonatal 6-hydroxydopamine or adult stage DSP-4 noradrenaline denervations: a quantitative radioautographic study.
Topics: Animals; Animals, Newborn; Autoradiography; Benzylamines; Cerebral Cortex; Denervation; Dopamine; Hydroxydopamines; Male; Neurotoxins; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Tritium | 1988 |
Central noradrenergic involvement in yohimbine excitation of acoustic startle: effects of DSP4 and 6-OHDA.
Topics: Animals; Benzylamines; Brain; Hydroxydopamines; Male; Neural Pathways; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Reflex, Startle; Spinal Cord; Yohimbine | 1985 |
AF64A produces long-term cognitive impairments following infusion into the lateral cerebral ventricles or the dorsal hippocampus: involvement of hippocampal cholinergic processes in learning and memory.
Topics: Animals; Avoidance Learning; Aziridines; Azirines; Benzylamines; Choline; Cholinergic Fibers; Discrimination Learning; Hippocampus; Hydroxydopamines; Male; Memory; Mental Recall; Neuromuscular Blocking Agents; Oxidopamine; Rats; Rats, Inbred F344 | 1985 |
Sympathectomy inhibits growth of a murine plasmacytoma tumor.
Topics: Animals; Animals, Newborn; Benzylamines; Body Temperature; Body Weight; Dopamine beta-Hydroxylase; Female; Hydroxydopamines; Immune Sera; Mice; Mice, Inbred BALB C; Nerve Growth Factors; Oxidopamine; Plasmacytoma; Reaction Time; Sympathectomy, Chemical | 1985 |
DSP-4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine) depletes noradrenaline in kitten visual cortex without altering the effects of monocular deprivation.
Topics: Amines; Animals; Benzylamines; Cats; Electrophysiology; Hydroxydopamines; Norepinephrine; Oxidopamine; Sensory Deprivation; Vision, Ocular; Visual Cortex | 1985 |
The hindlimb extension reflex is not a reliable marker of post-decapitation convulsions or spinal noradrenaline depletion in rats.
Topics: Animals; Animals, Newborn; Benzylamines; Brain; Hindlimb; Hydroxydopamines; Locus Coeruleus; Male; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Reflex; Seizures; Spinal Cord | 1985 |
Clonidine-induced sedation in rats: evidence for mediation by postsynaptic alpha 2-adrenoreceptors.
Topics: Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Benzylamines; Clonidine; Hydroxydopamines; Hypnotics and Sedatives; Male; Neurotoxins; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Synapses | 1982 |
Parallel changes in brain flunitrazepam binding and density of noradrenergic innervation.
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Benzylamines; Brain; Flunitrazepam; Hydroxydopamines; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, GABA-A; Sympathetic Nervous System | 1983 |
Heterogeneity of benzodiazepine receptors: experimental differences between [3H]flunitrazepam and [3H]ethyl-beta-carboline-3-carboxylate binding sites in rat brain membranes.
Topics: Age Factors; Animals; Anti-Anxiety Agents; Benzylamines; Brain; Carbolines; Flunitrazepam; Hydroxydopamines; Indoles; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, GABA-A; Tissue Distribution | 1983 |
[3H]RX 781094: a new antagonist ligand labels alpha 2-adrenoceptors in the rat brain cortex.
Topics: Adrenergic alpha-Antagonists; Animals; Benzylamines; Binding, Competitive; Cerebral Cortex; Dioxins; Hydroxydopamines; Idazoxan; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Reserpine | 1983 |
Neurotoxins and developing monoaminergic neurons.
Topics: Adrenergic Fibers; Amines; Animals; Animals, Newborn; Benzylamines; Blood-Brain Barrier; Dihydroxyphenylalanine; Hydroxydopamines; Nervous System; Oxidopamine; Rats | 1983 |
Effects of the selective noradrenergic neurotoxin DSP4 on cerebellar Purkinje neuron electrophysiology.
Topics: Amines; Animals; Benzylamines; Cerebellum; Electrophysiology; Hydroxydopamines; Male; Neurotoxins; Norepinephrine; Oxidopamine; Purkinje Cells; Rats; Rats, Inbred Strains | 1984 |
Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment.
Topics: Amines; Animals; Behavior, Animal; Benzylamines; Brain Chemistry; Desipramine; Dextroamphetamine; Dopamine; Hydroxydopamines; Male; Mice; Norepinephrine; Oxidopamine | 1984 |
Asymmetrical locomotor response to unilateral cortical injections of DSP-4.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amines; Animals; Behavior, Animal; Benzylamines; Caudate Nucleus; Cerebral Cortex; Dopamine; Functional Laterality; Hydroxydopamines; Injections; Locus Coeruleus; Male; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra | 1984 |
Noradrenaline and dopamine interaction in rat brain during development.
Topics: Adrenergic Fibers; Aging; Animals; Animals, Newborn; Benzylamines; Brain; Brain Stem; Cerebral Cortex; Denervation; Dopamine; Functional Laterality; Hydroxydopamines; Nerve Endings; Neurotoxins; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains | 1981 |
Hyperactivity of central noradrenergic and CRF systems is involved in social isolation-induced decrease in pentobarbital sleep.
Topics: Adrenergic Agents; Aggression; Animals; Behavior, Animal; Benzylamines; Brain; Corticotropin-Releasing Hormone; Hormone Antagonists; Male; Mice; Neurotoxins; Norepinephrine; Oxidopamine; Pentobarbital; Sleep; Social Environment; Social Isolation | 1995 |
Effects of the chemical denervation on the glial cells of the rat pineal gland: an immunocytochemical study during postnatal development.
Topics: Animals; Animals, Newborn; Benzylamines; Female; Glial Fibrillary Acidic Protein; Immunohistochemistry; Male; Neuroglia; Neurotoxins; Oxidopamine; Pineal Gland; Pregnancy; Rats; Rats, Wistar; S100 Proteins; Sympathectomy, Chemical; Vimentin | 1995 |
Neuronal gene expression in the waking state: a role for the locus coeruleus.
Topics: Adrenergic Fibers; Animals; Benzylamines; Brain; Cerebral Cortex; Cyclic AMP Response Element-Binding Protein; DNA-Binding Proteins; Early Growth Response Protein 1; Electroencephalography; Gene Expression Regulation; Genes, fos; Genes, Immediate-Early; Hippocampus; Immediate-Early Proteins; Locus Coeruleus; Neurons; Norepinephrine; Oxidopamine; Phosphorylation; Rats; Sleep; Sleep Deprivation; Sympathectomy, Chemical; Transcription Factors; Wakefulness | 1996 |
An ex vivo evaluation of regulatory role of biogenic amines in rat seminal vesicle after pharmacological manipulation.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Agents; Animals; Benzylamines; Catecholamines; Electric Stimulation; Injections, Spinal; Male; Neurotoxins; Oxidopamine; Pressure; Rats; Rats, Wistar; Seminal Vesicles; Serotonin Agents; Splanchnic Nerves | 1998 |
Endotoxin- and interleukin-1-induced hypophagia are not affected by adrenergic, dopaminergic, histaminergic, or muscarinic antagonists.
Topics: Adrenergic Antagonists; Animals; Benzylamines; Biogenic Amines; Dopamine Antagonists; Endotoxins; Escherichia coli; Feeding Behavior; Histamine Antagonists; Interleukin-1; Lipopolysaccharides; Male; Mice; Muscarinic Antagonists; Oxidopamine; Sympatholytics | 1999 |
Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins.
Topics: Benzylamines; Cell Differentiation; Cell Survival; Fluorouracil; Gamma Rays; Humans; Neuroblastoma; Neurotoxins; Oxidopamine; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Tretinoin; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1999 |
Microdialysates of amines and metabolites from core nucleus accumbens of freely moving rats are altered by dizocilpine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzylamines; Chromatography, High Pressure Liquid; Desipramine; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Male; Microdialysis; Motor Activity; Neuroprotective Agents; Neurotransmitter Agents; Norepinephrine; Nucleus Accumbens; Oxidopamine; Rats; Rats, Wistar; Reserpine; Serotonin | 2001 |
Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzylamines; Dose-Response Relationship, Drug; Frontal Lobe; Hypothalamus; Locus Coeruleus; Male; Morpholines; Neurotoxins; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Reboxetine; Swimming; Sympatholytics; Tegmentum Mesencephali | 2002 |
Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Behavior, Animal; Benzylamines; Catalepsy; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Haloperidol; Hippocampus; Homovanillic Acid; Hypothalamus; Locus Coeruleus; Male; Medial Forebrain Bundle; Nerve Degeneration; Neurotoxins; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Reaction Time; Serotonin; Substantia Nigra; Thalamus; Tyrosine | 2003 |
Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Basal Ganglia; Behavior, Animal; Benzylamines; Brain Chemistry; Catalepsy; Disease Models, Animal; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Locus Coeruleus; Male; Motor Activity; Norepinephrine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonin; Statistics, Nonparametric; Tyrosine | 2004 |
Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus.
Topics: Animals; Benzylamines; Clonidine; Dextroamphetamine; Dopamine Uptake Inhibitors; Electrophysiology; Lysergic Acid Diethylamide; Male; Neurons; Oxidopamine; Piperazines; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists; Sympathectomy, Chemical; Sympatholytics | 2004 |
The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Benzylamines; Cerebral Cortex; Citalopram; Desipramine; Dopamine beta-Hydroxylase; Fluoxetine; Hindlimb Suspension; Immunohistochemistry; Locus Coeruleus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Norepinephrine; Oxidopamine; Presynaptic Terminals; Raphe Nuclei; Selective Serotonin Reuptake Inhibitors | 2007 |
Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Benzylamines; Brain; Caffeine; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Male; Motor Activity; Neurotoxins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 2007 |
Noradrenergic modulation of the motor response induced by long-term levodopa administration in Parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Benzylamines; Brain; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Levodopa; Male; Movement; Neurotoxins; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Recovery of Function; Synaptic Transmission; Time; Treatment Outcome | 2009 |
Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances.
Topics: Animals; Benzylamines; Cognition Disorders; Dyskinesia, Drug-Induced; Levodopa; Locus Coeruleus; Male; Maze Learning; Medial Forebrain Bundle; Memory, Short-Term; Motor Activity; Neurodegenerative Diseases; Oxidopamine; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Substantia Nigra; Time Factors | 2009 |
Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
Topics: Animals; Benzylamines; Electrophysiological Phenomena; Extracellular Space; Fenclonine; Globus Pallidus; Male; Neurons; Norepinephrine; Oxidopamine; Parkinson Disease, Secondary; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Substantia Nigra; Sympatholytics | 2012 |
Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit.
Topics: Animals; Behavior, Animal; Benzylamines; Cerebrum; Disease Models, Animal; Dopamine; Exenatide; Male; Neuroprotective Agents; Norepinephrine; Oxidopamine; Parkinson Disease; Peptides; Rats; Rats, Wistar; Venoms | 2012 |
Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Topics: Adrenergic Agents; Adrenergic Neurons; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benzylamines; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Levodopa; Motor Activity; Nerve Degeneration; Oxidopamine; Parkinson Disease; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Ribosome Inactivating Proteins, Type 1; Saporins; Stereotyped Behavior | 2014 |
L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Benzylamines; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Idazoxan; Levodopa; Male; Microdialysis; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine 3-Monooxygenase | 2014 |
Additional noradrenergic depletion aggravates forelimb akinesia and abnormal subthalamic nucleus activity in a rat model of Parkinson's disease.
Topics: Action Potentials; Animals; Benzylamines; Disease Models, Animal; Dopamine; Forelimb; Male; Norepinephrine; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Subthalamic Nucleus | 2014 |
The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation.
Topics: Animals; Anxiety Disorders; Benzylamines; Biogenic Monoamines; Catalepsy; Corpus Striatum; Deep Brain Stimulation; Depressive Disorder; Dopamine; Frontal Lobe; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats, Sprague-Dawley; Subthalamic Nucleus | 2015 |
Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson's Disease.
Topics: Animals; Benzylamines; Corpus Striatum; Disease Models, Animal; Levodopa; Male; Norepinephrine; Oxidopamine; Pain; Parkinson Disease; Rats, Sprague-Dawley; Spinal Cord | 2016 |